Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 04, 2020

SELL
$103.87 - $120.36 $270,062 - $312,936
-2,600 Reduced 6.13%
39,800 $1.02 Million
Q1 2020

Apr 21, 2020

BUY
$65.95 - $98.35 $6,595 - $9,835
100 Added 0.24%
42,400 $70,000
Q4 2019

Feb 12, 2020

SELL
$74.65 - $98.46 $29,860 - $39,384
-400 Reduced 0.94%
42,300 $453,000
Q2 2019

Aug 06, 2019

BUY
N/A
1,200 Added 2.89%
42,700 $109,000
Q1 2019

May 06, 2019

SELL
N/A
-500 Reduced 1.19%
41,500 $297,000
Q4 2018

Feb 11, 2019

BUY
N/A
900 Added 2.19%
42,000 $15,000
Q3 2018

Nov 14, 2018

BUY
N/A
200 Added 0.49%
41,100 $709,000
Q2 2018

Aug 14, 2018

SELL
N/A
-900 Reduced 2.15%
40,900 $658,000
Q1 2018

May 14, 2018

SELL
N/A
-12,400 Reduced 22.88%
41,800 $520,000
Q4 2017

Feb 14, 2018

SELL
N/A
-11,100 Reduced 17.0%
54,200 $463,000
Q3 2017

Nov 13, 2017

BUY
N/A
10,100 Added 18.3%
65,300 $601,000
Q2 2017

Aug 14, 2017

BUY
N/A
55,200
55,200 $247,000

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.